Clinical efficacy of casirivimab and imdevimab in preventing COVID-19 in the Omicron BA.5 subvariant epidemic: a retrospective study
Ohtani et al., Research Square, doi:10.21203/rs.3.rs-6582593/v1
https://c19early.org/ohtani.html